• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Automated Cell Culture Equipment Market

    ID: MRFR/MED/7298-CR
    115 Pages
    Kinjoll Dey
    February 2020

    Automated Cell Culture Equipment Market Research Report Information by Lab Automation Type (Modular Automation and Whole Lab Automation), by Product Type (Consumables, Equipment and Software), Application (Biopharmaceutical Production, Tissue Engineering, Vaccine Production, Gene Therapy & Regenerative Medicine, Stem Cell Therapy, Toxicity Testing and Diagnostics), End User (Pharmaceutical & Biotechnology Companies, Research and Academic Institutes and Hospitals and Diagnostic Laboratories) - Forecast till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Automated Cell Culture Equipment Market Infographic
    Purchase Options

    Automated Cell Culture Equipment Market Summary

    The Global Automated Cell Culture Equipment Market is projected to grow from 0.97 USD Billion in 2024 to 2.12 USD Billion by 2035, reflecting a robust growth trajectory.

    Key Market Trends & Highlights

    Automated Cell Culture Equipment Key Trends and Highlights

    • The market is expected to achieve a compound annual growth rate (CAGR) of 7.37% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 2.12 USD Billion, indicating substantial growth potential.
    • In 2024, the market is valued at 0.97 USD Billion, laying a solid foundation for future expansion.
    • Growing adoption of automated cell culture technologies due to increased demand for high-throughput screening is a major market driver.

    Market Size & Forecast

    2024 Market Size 0.97 (USD Billion)
    2035 Market Size 2.12 (USD Billion)
    CAGR (2025-2035) 7.37%

    Major Players

    Tecan Trading AG, Siemens, Pfizer Inc., Hitachi, Ltd, Thermo Fisher Scientific Inc., Sartorius AG, Hamilton Company, Beckman Coulter, Inc., F. Hoffmann-La Roche Ltd., Perkinelmer, Inc., Anton Paar GmBH, Becton, Dickinson, and Company (U.S.), HiMedia Laboratories (India), GE Healthcare (U.S.), Lonza (Switzerland), CellGenix GmbH (Germany)

    Automated Cell Culture Equipment Market Drivers

    Market Growth Projections

    The Global Automated Cell Culture Equipment Market Industry is projected to experience substantial growth over the coming years. The market is expected to reach approximately 0.97 USD Billion in 2024 and is forecasted to grow to around 2.12 USD Billion by 2035. This growth trajectory suggests a robust demand for automated solutions in cell culture processes. The anticipated CAGR of 7.37% from 2025 to 2035 indicates a strong market potential, driven by various factors including technological advancements, increased investment in R&D, and a rising focus on personalized medicine. This upward trend highlights the importance of automated cell culture equipment in modern biopharmaceutical development.

    Rising Demand for Biopharmaceuticals

    The Global Automated Cell Culture Equipment Market Industry experiences a notable surge in demand driven by the increasing need for biopharmaceuticals. As the global population ages and chronic diseases rise, the biopharmaceutical sector is expected to expand significantly. In 2024, the market is valued at approximately 0.97 USD Billion, reflecting the industry's growth potential. This trend is likely to continue, with projections indicating a market size of 2.12 USD Billion by 2035. The CAGR of 7.37% from 2025 to 2035 suggests that automated cell culture equipment will play a crucial role in meeting the production demands of biopharmaceuticals.

    Increased Focus on Personalized Medicine

    The Global Automated Cell Culture Equipment Market Industry is significantly influenced by the growing emphasis on personalized medicine. As healthcare shifts towards tailored therapies, the demand for advanced cell culture techniques rises. Automated cell culture systems facilitate the development of patient-specific treatments by enabling high-throughput screening and efficient cell manipulation. This trend is expected to contribute to the market's expansion, with a projected growth from 0.97 USD Billion in 2024 to 2.12 USD Billion by 2035. The CAGR of 7.37% from 2025 to 2035 indicates that automated cell culture equipment will be integral to the future of personalized medicine.

    Technological Advancements in Automation

    Technological advancements in automation are pivotal for the Global Automated Cell Culture Equipment Market Industry. Innovations such as robotics, artificial intelligence, and machine learning enhance the efficiency and precision of cell culture processes. These technologies streamline workflows, reduce human error, and improve reproducibility, which are essential for research and production. As laboratories increasingly adopt automated solutions, the market is poised for growth. The anticipated increase in market size from 0.97 USD Billion in 2024 to 2.12 USD Billion by 2035 underscores the importance of these advancements in driving the adoption of automated cell culture equipment.

    Growing Investment in Research and Development

    Investment in research and development is a critical driver for the Global Automated Cell Culture Equipment Market Industry. As organizations strive to innovate and develop new therapies, the demand for sophisticated cell culture systems increases. Enhanced funding from both public and private sectors supports the development of automated solutions that improve research outcomes. The market's growth from 0.97 USD Billion in 2024 to 2.12 USD Billion by 2035 reflects this trend. The projected CAGR of 7.37% from 2025 to 2035 indicates that sustained investment in R&D will likely propel the adoption of automated cell culture equipment.

    Regulatory Support for Advanced Cell Culture Techniques

    Regulatory bodies are increasingly supporting the adoption of advanced cell culture techniques, which positively impacts the Global Automated Cell Culture Equipment Market Industry. Guidelines that promote the use of automated systems in research and production enhance compliance and safety in biopharmaceutical manufacturing. This regulatory support encourages investment in automated technologies, leading to market growth. With the market projected to grow from 0.97 USD Billion in 2024 to 2.12 USD Billion by 2035, the role of regulatory frameworks in facilitating the adoption of automated cell culture equipment cannot be understated. The anticipated CAGR of 7.37% from 2025 to 2035 further emphasizes this trend.

    Key Companies in the Automated Cell Culture Equipment Market market include

    Industry Developments

    Various developments are seen in the automated cell culture equipment market which is as follows:

      • In the year 2020, a japan based biotechnical organization named ThinkCyte Inc., came in a joint venture with Hitachi to develop an artificial intelligence system for strengthening cell analysis.
      • In the year 2019, Thermo Fisher introduced a new automated incubator for delivering and maintaining cells and microorganisms in a controlled environment.
      • In June of 2020, ThermoGnesis Corp., a pharmaceutical company, launched an X-series cell culturing products at a commercial level.
      • In May of 2019, Sartorius AG brought into being an automated micro-bioreactor, called Ambr 15 Cell Culture.
      • In the year 2020, HORIBA Medical and CellaVision collaborated and produced an automated digital cell morphology solution. 

    Future Outlook

    Automated Cell Culture Equipment Market Future Outlook

    The Automated Cell Culture Equipment Market is projected to grow at a 7.37% CAGR from 2024 to 2035, driven by technological advancements, increasing demand for biopharmaceuticals, and enhanced research capabilities.

    New opportunities lie in:

    • Develop automated systems for personalized medicine applications.
    • Invest in AI-driven analytics for optimized cell culture processes.
    • Expand product lines to include sustainable and eco-friendly materials.

    By 2035, the market is expected to achieve substantial growth, reflecting advancements and increased adoption across various sectors.

    Market Segmentation

    Report Overview

    • Recent Developments
    • Competitive Landscape
    • Regional Analysis
    • Automated Cell Culture Equipment Market Segmentation
    • Value Chain Analysis
    • Market Dynamics
    • COVID19 Analysis
    • Automated Cell Culture Equipment Market Overview

    Regional Analysis

    • CellGenix GmbH (Germany).
    • Lonza (Switzerland)
    • GE Healthcare (U.S.)
    • HiMedia Laboratories (India)
    • Anton Paar GmBH . Becton, Dickinson, and Company (U.S.)
    • Perkinelmer, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Beckman Coulter, Inc.
    • Hamilton Company
    • Sartorius AG
    • Thermo Fisher Scientific Inc.
    • Hitachi, Ltd
    • Pfizer Inc.
    • Siemens
    • Tecan Trading AG
    • In the year 2020, HORIBA Medical and CellaVision collaborated and produced an automated digital cell morphology solution. 
    • In May of 2019, Sartorius AG brought into being an automated micro-bioreactor, called Ambr 15 Cell Culture.
    • In June of 2020, ThermoGnesis Corp., a pharmaceutical company, launched an X-series cell culturing products at a commercial level.
    • In the year 2019, Thermo Fisher introduced a new automated incubator for delivering and maintaining cells and microorganisms in a controlled environment.
    • In the year 2020, a japan based biotechnical organization named ThinkCyte Inc., came in a joint venture with Hitachi to develop an artificial intelligence system for strengthening cell analysis.
    • Recent Developments
    • Competitive Landscape
    • Regional Analysis
    • Automated Cell Culture Equipment Market Segmentation
    • Value Chain Analysis
    • Market Dynamics
    • COVID19 Analysis
    • Automated Cell Culture Equipment Market Overview

    Recent Development

    • In the year 2020, HORIBA Medical and CellaVision collaborated and produced an automated digital cell morphology solution. 
    • In May of 2019, Sartorius AG brought into being an automated micro-bioreactor, called Ambr 15 Cell Culture.
    • In June of 2020, ThermoGnesis Corp., a pharmaceutical company, launched an X-series cell culturing products at a commercial level.
    • In the year 2019, Thermo Fisher introduced a new automated incubator for delivering and maintaining cells and microorganisms in a controlled environment.
    • In the year 2020, a japan based biotechnical organization named ThinkCyte Inc., came in a joint venture with Hitachi to develop an artificial intelligence system for strengthening cell analysis.
    • Recent Developments
    • Competitive Landscape
    • Regional Analysis
    • Automated Cell Culture Equipment Market Segmentation
    • Value Chain Analysis
    • Market Dynamics
    • COVID19 Analysis
    • Automated Cell Culture Equipment Market Overview

    Competitive Landscape

    • CellGenix GmbH (Germany).
    • Lonza (Switzerland)
    • GE Healthcare (U.S.)
    • HiMedia Laboratories (India)
    • Anton Paar GmBH . Becton, Dickinson, and Company (U.S.)
    • Perkinelmer, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Beckman Coulter, Inc.
    • Hamilton Company
    • Sartorius AG
    • Thermo Fisher Scientific Inc.
    • Hitachi, Ltd
    • Pfizer Inc.
    • Siemens
    • Tecan Trading AG
    • In the year 2020, HORIBA Medical and CellaVision collaborated and produced an automated digital cell morphology solution. 
    • In May of 2019, Sartorius AG brought into being an automated micro-bioreactor, called Ambr 15 Cell Culture.
    • In June of 2020, ThermoGnesis Corp., a pharmaceutical company, launched an X-series cell culturing products at a commercial level.
    • In the year 2019, Thermo Fisher introduced a new automated incubator for delivering and maintaining cells and microorganisms in a controlled environment.
    • In the year 2020, a japan based biotechnical organization named ThinkCyte Inc., came in a joint venture with Hitachi to develop an artificial intelligence system for strengthening cell analysis.
    • Recent Developments
    • Competitive Landscape
    • Regional Analysis
    • Automated Cell Culture Equipment Market Segmentation
    • Value Chain Analysis
    • Market Dynamics
    • COVID19 Analysis
    • Automated Cell Culture Equipment Market Overview

    Automated Cell Culture Equipment Market on end-user

    • CellGenix GmbH (Germany).
    • Lonza (Switzerland)
    • GE Healthcare (U.S.)
    • HiMedia Laboratories (India)
    • Anton Paar GmBH . Becton, Dickinson, and Company (U.S.)
    • Perkinelmer, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Beckman Coulter, Inc.
    • Hamilton Company
    • Sartorius AG
    • Thermo Fisher Scientific Inc.
    • Hitachi, Ltd
    • Pfizer Inc.
    • Siemens
    • Tecan Trading AG
    • In the year 2020, HORIBA Medical and CellaVision collaborated and produced an automated digital cell morphology solution. 
    • In May of 2019, Sartorius AG brought into being an automated micro-bioreactor, called Ambr 15 Cell Culture.
    • In June of 2020, ThermoGnesis Corp., a pharmaceutical company, launched an X-series cell culturing products at a commercial level.
    • In the year 2019, Thermo Fisher introduced a new automated incubator for delivering and maintaining cells and microorganisms in a controlled environment.
    • In the year 2020, a japan based biotechnical organization named ThinkCyte Inc., came in a joint venture with Hitachi to develop an artificial intelligence system for strengthening cell analysis.
    • Recent Developments
    • Competitive Landscape
    • Regional Analysis
    • Automated Cell Culture Equipment Market Segmentation
    • Value Chain Analysis
    • Market Dynamics
    • COVID19 Analysis
    • Automated Cell Culture Equipment Market Overview

    Report Scope

    Report Attribute/Metric Details
    Market Size 2023 0.90 (USD Billion)
    Market Size 2024 0.97 (USD Billion)
    Market Size 2032 1.71 (USD Billion)
    Compound Annual Growth Rate (CAGR) 7.43 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Tecan Trading AG, Hamilton Company, Beckman Coulter, Inc., Pfizer Inc., Hitachi, Ltd, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Anton Paar GmBH, Sartorius AG, Perkinelmer, Inc., and Siemens
      Key Market Opportunities   Growing research & development (R&D) initiatives in the pharmaceutical industry
      Key Market Drivers ·  The rising prevalence of cancer and other chronic disorders demands the discovery of newer and more effective drugs for their treatment. ·  The growing incidence of cancer and other chronic diseases is anticipated to fuel the market growth

    Market Highlights

    Author
    Kinjoll Dey
    Research Analyst Level I

    He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

    Leave a Comment

    FAQs

    What is the projected market value of the automated cell culture equipment market?

    Automated cell culture equipment market is touted to record a substantial market valuation of USD 1.71 Billion by 2032.

    What is the estimated growth rate of the automated cell culture equipment market?

    Automated cell culture equipment market is projected to register a moderate 7.43% CAGR in the forecast period.

    Which factors are poised to drive the automated cell culture equipment market growth?

    The massive growth of the automated cell culture equipment market is driven by the growing R&D projects in the pharmaceutical industry.

    Which type is touted to witness the highest growth?

    The modular automation segment is expected to observe substantial demand over the review period.

    Which region is expected to observe the highest growth?

    The APAC is poised to secure the highest CAGR.

    What is the application of the automated cell culture equipment market expected to witness the highest growth?

    The stem cell therapy segment is slated to mature as the fastest-growing segment.

    Who are the significant players operative in the automated cell culture equipment market?

    A few eminent market players functioning in the global automated cell culture equipment market are Siemens, Pfizer Inc., Thermo Fisher Scientific Inc., Hitachi, Ltd, among others.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials